🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy cardiologist just high-fived me at my checkup lol — what worked for you? Page 2

My cardiologist just high-fived me at my checkup lol — what worked for you?

DataDave Thu, Aug 7, 2025 at 9:26 PM 11 replies 1,375 viewsPage 2 of 3
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Aug 8, 2025 at 12:53 AM#6
TrialTracker_MD said:
Metabolic syndrome resolution on cardiovascular risk: I went from meeting 3 of 5 diagnostic criteria to meeting ZERO after 11 months of treatment.

This is where I part company with the consensus forming above. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

5 8NurseKim_ATL, paul_denver, TinaHashiRN and 2 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Aug 8, 2025 at 2:14 AM#7
DataDave said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.
DataDave said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

Last edited: Aug 8, 2025 at 4:14 AM
6 9KristenIndy, MarkLI_maint, Dr.PeteFamMed and 3 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Aug 8, 2025 at 3:35 AM#8
LarryQC_SD said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.
LarryQC_SD said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

Last edited: Aug 8, 2025 at 7:35 AM
7 10SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 4 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Aug 8, 2025 at 4:56 AM#9

One thing that is still open after roxy_nash’s answer:

Was that from a primary source or from a summary of one?

Last edited: Aug 8, 2025 at 10:56 AM
8 11lori_vegas, Dr.PulmRoch, maya_sedona and 5 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Aug 8, 2025 at 11:25 AM#10
DebRD_ATL said:
LarryQC_SD said: ...we don't know the long-term effects of cardiovascular risk...

6 month update on cardiovascular risk: down 41 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

14 14Dr.GutHealth, amsterdam_pete, LondonLisa and 11 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register